FDA Drug Safety Communication: FDA to review study examining use of oral fluconazole (Diflucan) in pregnancy

[FDA]

The U.S. Food and Drug Administration (FDA) is evaluating the results of a Danish study1 that concludes there is a possible increased risk of miscarriage with the use of oral fluconazole (Diflucan) for yeast infections.


Baca selengkapnya di : http://www.fda.gov...